These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 30531673)
21. Varicella zoster virus reactivation in hemodialysis patients: manifestations, treatment, complications and outcome. Mesar I; Basić-Jukić N; Hudolin T; Katalinić L; Kes P Acta Clin Croat; 2011 Dec; 50(4):549-52. PubMed ID: 22649885 [TBL] [Abstract][Full Text] [Related]
22. Effective Clearance of Aciclovir Using Hemodiafiltration in a Patient With Neurotoxicity. Gallacher PJ; Phelan PJ Artif Organs; 2017 May; 41(5):496-497. PubMed ID: 28543384 [No Abstract] [Full Text] [Related]
23. [Acyclovir-induced neurotoxicity and acute kidney injury in an elderly diabetic patient treated with valacyclovir: report of a case]. Sagawa N; Tsurutani Y; Nomura K; Okuyama T; Kondo M; Sata A; Miyao M; Mizuno Y Nihon Ronen Igakkai Zasshi; 2014; 51(6):581-5. PubMed ID: 25749332 [TBL] [Abstract][Full Text] [Related]
24. Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases. Brandariz-Nuñez D; Correas-Sanahuja M; Maya-Gallego S; Martín Herranz I J Clin Pharm Ther; 2021 Aug; 46(4):918-926. PubMed ID: 34146428 [TBL] [Abstract][Full Text] [Related]
26. Altered mental status from acyclovir. Martinez-Diaz GJ; Hsia R J Emerg Med; 2011 Jul; 41(1):55-8. PubMed ID: 19926428 [TBL] [Abstract][Full Text] [Related]
27. Neurotoxicity of valacyclovir in peritoneal dialysis: a pharmacokinetic study. Izzedine H; Mercadal L; Aymard G; Launay-Vacher V; Martinez V; Issad B; Deray G Am J Nephrol; 2001; 21(2):162-4. PubMed ID: 11359026 [TBL] [Abstract][Full Text] [Related]
28. [A patient with thyroid carcinoma who developed consciousness disturbance during acyclovir administration for herpes zoster]. Matsumoto R; Yoshida T; Tabata K; Nakagawa S; Yanagisawa N Rinsho Shinkeigaku; 1996 Apr; 36(4):590-3. PubMed ID: 8810856 [TBL] [Abstract][Full Text] [Related]
29. A Case Report of Neurotoxicity After Prolonged Doses of Acyclovir in a Patient With Renal Dysfunction. Umoru GO; Shah PJ; Tariq F J Pharm Pract; 2020 Apr; 33(2):217-221. PubMed ID: 30669921 [TBL] [Abstract][Full Text] [Related]
30. Hemodialysis removal of acyclovir. Leikin JB; Shicker L; Orlowski J; Blair AT; McAllister K Vet Hum Toxicol; 1995 Jun; 37(3):233-4. PubMed ID: 7571352 [TBL] [Abstract][Full Text] [Related]
31. [Acyclovir neurotoxicity vs. encephalitis due to varicella zoster in a patient with chronic renal failure]. Sanz-Fernández G; Franco-Macías E; Rodríguez-Uranga JJ; López-Muñoz MM Rev Neurol; 2004 Aug 16-31; 39(4):400. PubMed ID: 15340906 [No Abstract] [Full Text] [Related]
32. Valacyclovir neurotoxicity: clinical experience and review of the literature. Asahi T; Tsutsui M; Wakasugi M; Tange D; Takahashi C; Tokui K; Okazawa S; Okudera H Eur J Neurol; 2009 Apr; 16(4):457-60. PubMed ID: 19187258 [TBL] [Abstract][Full Text] [Related]
34. Differential diagnosis of central nervous system involvement in a patient treated with acyclovir. von Euler M; Axelsson G; Helldén A Ther Drug Monit; 2013 Aug; 35(4):417-9. PubMed ID: 23851913 [TBL] [Abstract][Full Text] [Related]
35. A case of chronic renal dysfunction following treatment with oral acyclovir. Sodhi PK; Ratan SK Scand J Infect Dis; 2003; 35(10):770-2. PubMed ID: 14606623 [TBL] [Abstract][Full Text] [Related]
36. [Risk of CNS adverse effects of aciclovir and valaciclovir. Watch the renal function in treatment of herpes simplex and herpes zoster]. Helldén A; Bergman U; Dwyer R; Medin C; Molanaei H; Ståhle L; Thylén P; Odar-Cederlöf I Lakartidningen; 2007 Jun 13-26; 104(24-25):1916-20. PubMed ID: 17674672 [No Abstract] [Full Text] [Related]
37. More about acyclovir neurotoxicity in patients on haemodialysis. Gómez Campderá FJ; Verde E; Vozmediano MC; Valderrábano F Nephron; 1998; 78(2):228-9. PubMed ID: 9496746 [No Abstract] [Full Text] [Related]
38. Neurotoxicity related to valganciclovir in a child with impaired renal function: usefulness of therapeutic drug monitoring. Peyrière H; Jeziorsky E; Jalabert A; Cociglio M; Benketira A; Blayac JP; Hansel S; Margueritte G; Hillaire-Buys D Ann Pharmacother; 2006 Jan; 40(1):143-6. PubMed ID: 16368917 [TBL] [Abstract][Full Text] [Related]
39. Herpes zoster encephalopathy or acyclovir neurotoxicity: a management dilemma. Sacchetti D; Alawadhi A; Albakour M; Rapose A BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24777077 [TBL] [Abstract][Full Text] [Related]
40. A pharmacokinetic and safety evaluation of a 28 day course of oral acyclovir in elderly patients with herpes zoster. Moss PJ; Wood MJ; Crooks RJ; Gallagher J; McKendrick MW J Antimicrob Chemother; 1995 Jul; 36(1):271-3. PubMed ID: 8537281 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]